[March 11, 2014]

Research and Markets: The US Specialty Pharmaceutical Market Report: 2013 Edition

Research and Markets (http://www.researchandmarkets.com/research/d447fb/the_us_specialty) has announced the addition of the "The US Specialty Pharmaceutical Market Report: 2013 Edition" report to their offering.

Specialty pharmaceuticals are defined as a new, rapidly growing drugs and biologics that are manufactured as a result of continued advancements in drug technology and design. These pharmaceuticals are specialized, high cost products which can be difficult to administer and may require patient monitoring. Specialty pharmaceuticals are utilized as complex therapies for complex chronic diseases such as cancer, hemophilia, multiple sclerosis, HIV, hepatitis C, apart from others. Some of the specialized drugs that are used for treating such conditions meet all the three H's: High Cost, High Complexity and High Touch and they require extensive education for safe and cost-effective use. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.

Specialty pharmacy is a special class of provider that are primarily responsible for distributing and dispensing the pharmaceutical as specialty pharmaceutical require specialized shipping and temperature-controlled storing and handling. Specialty pharmacy can be owned by stand-alone companies or large pharmacy chains. However, some drug wholesalers are also capable of shipping the specialty pharmaceuticals. There exists a substantial incentive for companies to research and develop products that address the unmet need of the patients as the specialty pharmaceutical market has the ability to sustain the high cost of these products thereby additionally offering a business perspective for the biopharmaceutical companies.

The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Some of the noteworthy trends and developments of this industry include rising Medicare enrollment, novel specialty products in pipeline, conversion of patents to generic drugs, increased spending on specialty drugs and ongoing merger & acquisition activities. However, the growth of the industry is being hindered by lack of rigorous clinical trials, sluggish pace of innovation and inappropriate use of therapeutic drugs.

The specialty pharmaceutical market witnesses fierce competition with numerous top notch players. The fierce competition prevailing in the US specialty pharmaceutical industry has been studied on a number of parameters such as competing drugs, mail pharmacies and distributors. Company profiles of leading players are also presented in the report.

Key Topics Covered

1. Overview

1.1 Specialty Pharmaceuticals Vs Traditional Drugs

1.2 Applications of Specialty Pharmaceuticals

1.3 Specialty Pharmacy Services

1.4 Specialty Product Distribution

1.5 Specialty Pharma Manufacturer Services

1.6 Value Proposition of Specialty Pharmacy

2. Market Size

2.1 Pharmaceutical Market

2.2 The US Specialty Pharmaceutical Market

3. Market Dynamics

3.1 Growth Drivers

3.2 Trends and Developments

3.3 Challenges

4. Competitive Landscape

4.1 Competition by Drugs

4.2 Competition by Mail Pharmacy

4.3 Competition by Specialty Distributor

5. Company Profiles

6. Market Outlook

6.1 Market Forecast

6.2 Forecast Methodology

Companies Mentioned

- Amgen

- Eli Lilly and Company

- Johnson & Johnson

- Novo Nordisk

- Pfizer

- Roche

For more information visit http://www.researchandmarkets.com/research/d447fb/the_us_specialty

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

[ Back To TMCnet.com's Homepage ]